Sunshine Biopharma Book Value Per Share vs. Cash Per Share
| SBFMW Stock | USD 0.17 0.04 20.95% |
Book Value Per Share | First Reported 2010-12-31 | Previous Quarter 1.7 K | Current Value 1.8 K | Quarterly Volatility 1 K |
For Sunshine Biopharma profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Sunshine Biopharma to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Sunshine Biopharma Warrant utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Sunshine Biopharma's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Sunshine Biopharma Warrant over time as well as its relative position and ranking within its peers.
Sunshine |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sunshine Biopharma. If investors know Sunshine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sunshine Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.21) | Revenue Per Share 197.42 | Quarterly Revenue Growth 0.416 | Return On Assets (0.11) | Return On Equity (0.18) |
The market value of Sunshine Biopharma is measured differently than its book value, which is the value of Sunshine that is recorded on the company's balance sheet. Investors also form their own opinion of Sunshine Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Sunshine Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sunshine Biopharma's market value can be influenced by many factors that don't directly affect Sunshine Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sunshine Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sunshine Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sunshine Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Sunshine Biopharma Cash Per Share vs. Book Value Per Share Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Sunshine Biopharma's current stock value. Our valuation model uses many indicators to compare Sunshine Biopharma value to that of its competitors to determine the firm's financial worth. Sunshine Biopharma Warrant is currently regarded as top stock in book value per share category among its peers. It also is currently regarded as top stock in cash per share category among its peers fabricating about 0.14 of Cash Per Share per Book Value Per Share. The ratio of Book Value Per Share to Cash Per Share for Sunshine Biopharma Warrant is roughly 6.95 . At this time, Sunshine Biopharma's Book Value Per Share is fairly stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Sunshine Biopharma by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Sunshine Cash Per Share vs. Book Value Per Share
Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Sunshine Biopharma |
| = | 12.52 X |
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Sunshine Biopharma |
| = | 1.80 X |
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
Sunshine Cash Per Share Comparison
Sunshine Biopharma is currently under evaluation in cash per share category among its peers.
Sunshine Biopharma Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Sunshine Biopharma, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Sunshine Biopharma will eventually generate negative long term returns. The profitability progress is the general direction of Sunshine Biopharma's change in net profit over the period of time. It can combine multiple indicators of Sunshine Biopharma, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 696.1 K | 730.9 K | |
| Operating Income | -4.8 M | -4.5 M | |
| Income Before Tax | -4.1 M | -4.3 M | |
| Net Loss | -4.5 M | -4.7 M | |
| Income Tax Expense | 395.2 K | 207 K | |
| Total Other Income Expense Net | 674.4 K | 708.1 K | |
| Net Loss | -11.2 M | -10.6 M | |
| Net Interest Income | 602.3 K | 632.4 K | |
| Net Loss | -26.8 M | -25.4 M | |
| Interest Income | 736 K | 460 K | |
| Change To Netincome | 12.3 M | 12.9 M | |
| Net Loss | (370.41) | (388.93) | |
| Income Quality | 1.95 | 2.04 | |
| Net Income Per E B T | 1.10 | 0.77 |
Sunshine Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Sunshine Biopharma. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Sunshine Biopharma position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Sunshine Biopharma's important profitability drivers and their relationship over time.
Use Sunshine Biopharma in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sunshine Biopharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sunshine Biopharma will appreciate offsetting losses from the drop in the long position's value.Sunshine Biopharma Pair Trading
Sunshine Biopharma Warrant Pair Trading Analysis
The ability to find closely correlated positions to Sunshine Biopharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sunshine Biopharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sunshine Biopharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sunshine Biopharma Warrant to buy it.
The correlation of Sunshine Biopharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sunshine Biopharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sunshine Biopharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sunshine Biopharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Sunshine Biopharma position
In addition to having Sunshine Biopharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Compulsion Thematic Idea Now
Compulsion
Companies involved in research, development, and manufacturing of products with compulsion characteristics such as cigarettes, addictive drugs and alcohol. The Compulsion theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Compulsion Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Sunshine Stock Analysis
When running Sunshine Biopharma's price analysis, check to measure Sunshine Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sunshine Biopharma is operating at the current time. Most of Sunshine Biopharma's value examination focuses on studying past and present price action to predict the probability of Sunshine Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sunshine Biopharma's price. Additionally, you may evaluate how the addition of Sunshine Biopharma to your portfolios can decrease your overall portfolio volatility.